Skip to main content
. Author manuscript; available in PMC: 2024 May 16.
Published in final edited form as: Am J Gastroenterol. 2023 Jun 22;118(9):1679–1683. doi: 10.14309/ajg.0000000000002332

Table 4.

Multivariate logistic regression of factors related to ustekinumab treatment response

Characteristic Odds ratio (CI) P value
Ustekinumab doses 0.4 (0.2–1.2) 0.122
Failure of single or dual SIT agents 0.05 (0.01–2.69) 0.143
Total doses of SIT 0.9 (0.6–1.3) 0.576
Male sex 0.22 (0.01–3.42) 0.277

SIT, selective immunosuppressive therapy.